0001213900-21-057325.txt : 20211108
0001213900-21-057325.hdr.sgml : 20211108
20211108160521
ACCESSION NUMBER: 0001213900-21-057325
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211104
FILED AS OF DATE: 20211108
DATE AS OF CHANGE: 20211108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KEYSER D JEFFREY
CENTRAL INDEX KEY: 0001393516
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39318
FILM NUMBER: 211387889
MAIL ADDRESS:
STREET 1: 4848 LOOP CENTRAL DRIVE
STREET 2: SUITE 700
CITY: HOUSTON
STATE: TX
ZIP: 77081
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantern Pharma Inc.
CENTRAL INDEX KEY: 0001763950
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463973463
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1920 MCKINNEY AVENUE
STREET 2: 7TH FLOOR
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: 972-277-1136
MAIL ADDRESS:
STREET 1: 1920 MCKINNEY AVENUE
STREET 2: 7TH FLOOR
CITY: DALLAS
STATE: TX
ZIP: 75201
FORMER COMPANY:
FORMER CONFORMED NAME: Lantern Pharma
DATE OF NAME CHANGE: 20190108
4
1
ownership.xml
X0306
4
2021-11-04
0
0001763950
Lantern Pharma Inc.
LTRN
0001393516
KEYSER D JEFFREY
1920 MCKINNEY AVENUE, 7TH FLOOR
DALLAS
TX
75201
1
0
0
0
Stock Option (Right to Buy)
10.32
2021-11-04
4
A
0
3200
0.00
A
2031-11-04
Common Stock
3200
3200
D
The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing upon December 4, 2021.
/s/ Donald Jeffrey Keyser
2021-11-05